Anzeige
Mehr »
Login
Sonntag, 03.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
Technischer Ausbruch: Diese Kupferaktie ist in den letzten 52 Wochen um 300 % gestiegen! Der Durchbruch läuft!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P8F1 | ISIN: CA74764Y2050 | Ticker-Symbol: 0K91
Tradegate
30.10.24
09:42 Uhr
4,920 Euro
+0,800
+19,42 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
QUANTUM BIOPHARMA LTD Chart 1 Jahr
5-Tage-Chart
QUANTUM BIOPHARMA LTD 5-Tage-Chart
RealtimeGeldBriefZeit
4,1204,48002.11.
3,9404,30001.11.

Aktuelle News zur QUANTUM BIOPHARMA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiQuantum Biopharma Ltd: Quantum Biopharma begins trial sentinel dosing3
DiQuantum BioPharma startet Phase-1-Studie für Multiple-Sklerose-Behandlung13
DiQuantum BioPharma initiates phase 1 multiple sclerosis trial6
DiQuantum Biopharma Ltd.: Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 in Australia193TORONTO, ON / ACCESSWIRE / October 29, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio...
► Artikel lesen
DiQuantum Biopharma Ltd. - 6-K, Report of foreign issuer3
22.10.Quantum Biopharma Ltd.: Quantum Biopharma Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing103To assist enquiries the copy of the complaint can be viewed by clicking the following link: Quantum Bio Pharma Complaint TORONTO, ON / ACCESSWIRE / October 22, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91)...
► Artikel lesen
21.10.Quantum BioPharma sues CIBC and RBC seeking $700M in damages9
21.10.Quantum Biopharma Ltd: Quantum Biopharma seeks $700M (U.S.) in "spoofing" suit3
21.10.Quantum Biopharma Ltd. - 6-K, Report of foreign issuer1
21.10.Quantum BioPharma alleges major market manipulation4
21.10.Quantum BioPharma Ltd.: Quantum BioPharma Files a US Federal Lawsuit Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing232Christian Attar Law Firm and Freedman Normand Friedland LLP, in conjunction with forensic investigators, have uncovered evidence of a potential multi-year market manipulation scheme that has caused...
► Artikel lesen
07.10.Quantum Biopharma Ltd: Quantum Bio investment Celly signs distribution deal10
07.10.Quantum BioPharma Ltd. Provides Update from Celly Nutrition Signing a Master Distribution Agreement with FUSION Distribution Group across Puerto Rico, The Caribbean, and parts of Central and South America374TORONTO, ON / ACCESSWIRE / October 7, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"), provides an update by way of a news release issued by Celly Nutrition Corp....
► Artikel lesen
07.10.Quantum Biopharma Ltd. - 6-K, Report of foreign issuer5
28.09.Quantum Biopharma Ltd: Quantum Bio hires Cambridge, Life Water, King Tide5
28.09.Quantum Biopharma Ltd.: Quantum Biopharma Provides Corporate Update462TORONTO, ON / ACCESSWIRE / September 27, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company...
► Artikel lesen
25.09.Quantum Biopharma Ltd.: Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US253TORONTO, ON / ACCESSWIRE / September 25, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company...
► Artikel lesen
16.09.Quantum Biopharma Ltd. - 6-K, Report of foreign issuer5
14.09.Quantum Biopharma Ltd: Quantum Biopharma closes $36 private placement7
14.09.Quantum BioPharma Ltd.: Quantum BioPharma Closes Private Placement Offering859Toronto, Ontario--(Newsfile Corp. - September 13, 2024) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K9) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated...
► Artikel lesen
Seite:  Weiter >>
125 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,5,4